SIFROL Tablet
Pramipexole (as diHCl monohydrate)
700 mg
ACTAVIS ITALY S.P.A.
| Pack size | 30's Pack |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 6.29 AED |
Indications
SIFROL Tablet is used for:
For the treatment of signs and symptoms of idiopathic Parkinson's disease
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Pramipexole (as diHCl monohydrate) :
Mechanism of Action
The precise mechanism of action of Pramipexole as a treatment for Parkinson's disease is unknown, although it is believed to be related to its ability to stimulate dopamine receptors in the striatum.
Note
SIFROL 700 mg Tablet manufactured by ACTAVIS ITALY S.P.A.. Its generic name is Pramipexole (as diHCl monohydrate). SIFROL is availble in Saudi Arabia.
Farmaco SA drug index information on SIFROL Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.
Some other brands of Pramipexole (as diHCl monohydrate) :
Prolonged-release Tablet
Dopaxol PR
0.375 mg
TABUK PHARMACEUTICAL MANUFACTURING CO
Prolonged-release Tablet
Dopaxol PR
0.75 mg
TABUK PHARMACEUTICAL MANUFACTURING CO
Prolonged-release Tablet
Dopaxol PR
1.5 mg
TABUK PHARMACEUTICAL MANUFACTURING CO
Prolonged-release Tablet
Dopaxol PR
3 mg
TABUK PHARMACEUTICAL MANUFACTURING CO